These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8214916

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Ion composition and rheology of airway liquid from cystic fibrosis fetal tracheal xenografts.
    Baconnais S, Tirouvanziam R, Zahm JM, de Bentzmann S, Péault B, Balossier G, Puchelle E.
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):605-11. PubMed ID: 10100991
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis.
    Knowles MR, Olivier K, Noone P, Boucher RC.
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S65-9. PubMed ID: 7533608
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
    Hirsh AJ, Sabater JR, Zamurs A, Smith RT, Paradiso AM, Hopkins S, Abraham WM, Boucher RC.
    J Pharmacol Exp Ther; 2004 Dec; 311(3):929-38. PubMed ID: 15273255
    [Abstract] [Full Text] [Related]

  • 31. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.
    Middleton PG, Geddes DM, Alton EW.
    Thorax; 1993 Aug; 48(8):812-6. PubMed ID: 8211871
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis.
    Sanders NN, Franckx H, De Boeck K, Haustraete J, De Smedt SC, Demeester J.
    Thorax; 2006 Nov; 61(11):962-8. PubMed ID: 17071834
    [Abstract] [Full Text] [Related]

  • 35. Exercise inhibits epithelial sodium channels in patients with cystic fibrosis.
    Hebestreit A, Kersting U, Basler B, Jeschke R, Hebestreit H.
    Am J Respir Crit Care Med; 2001 Aug 01; 164(3):443-6. PubMed ID: 11500347
    [Abstract] [Full Text] [Related]

  • 36. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
    Hansen G, Hoffjan S, Mosler K, Schuster A.
    Lung; 2001 Aug 01; 179(3):185-94. PubMed ID: 11891608
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.